Where does CuRNA, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CuRNA, Inc. ranks #3,623 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CuRNA, Inc. hold?

CuRNA, Inc. holds 101 US utility patents granted between 2015 and 2023, spanning 12 technology areas.

What is CuRNA, Inc.'s Innovation Score?

CuRNA, Inc. has an Innovation Score of 37.8 out of 100 (top 42% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is CuRNA, Inc.'s patent grant rate increasing or decreasing?

CuRNA, Inc.'s recent grant velocity is -88% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for CuRNA, Inc.'s patents?

CuRNA, Inc.'s patents average 14.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CuRNA, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

CuRNA, Inc.

Q: What technology areas does CuRNA, Inc. focus on?

CuRNA, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 100 patents. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 101 granted patents across 12 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Curna ranks #3,623 of 49,997 tracked US assignees by granted-patent volume, with 101 patents across 12 technology areas.

#3,623
of 49,997 US assignees by volume: Top 42%
by Innovation Score (37.8/100): 14.1
avg claims per patent: -88%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3623 · US Corporation #3,623 · 101 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 101 grants
TOP-DECILE #3,623/49,997
PHOTO-FINISH Chang Chun Petrochem…
CPC-FOCUS A61P · 12 areas
INNOV-THIN 37.8/100
CLAIMS-RICH 14.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -88% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Chang Chun Petrochemical Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Binj Laboratories · near

38
CuRNA · this assignee

38
Custom Molded Products · near

38
ESW Holdings · near

38
Network-1 · near

38
3D Lighting… · lowest

7

What this shows Curna's Innovation Score is 37.8/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Curna's grants concentrate

CuRNA, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 99% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (27 grants) versus a trough of 1 in 2023. By volume, Curna sits between Chang Chun Petrochemical Co., Ltd. and HM.CLAUSE, Inc..

Curna's three-year grant acceleration

From 2019–2021 to 2022–2024, CuRNA, Inc. moved from 23 to 4 grants (0.17x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,125. See the growth leaderboard.

Chang Chun Petroc…

101
Chimei

101
Consiglio Naziona…

101
CPG

101
Delphi Internatio…

101
FCI Americas Tech…

101
Fameccanica Data…

101
HM Clause

101
Curna ◀

101

What this shows CuRNA holds 101 patents at rank #3,623, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CuRNA

By rank, the assignees closest to #3,623 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in CuRNA's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CuRNA, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Network-1 Technologies, Inc. 38 Custom Molded Products, LLC 38 Binj Laboratories, Inc. 38 ESW Holdings, Inc. 38

Similar claim depth

Nearest assignees by average claims per patent (14.1 here).

Brown University 14.1 avg Paul Scherrer Institut 14.1 avg Sharp NEC Display Solutions, Ltd. 14.1 avg University OF Science AND Technology OF China 14.1 avg

Curna's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

CuRNA, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	27	26.7%
2016	10	9.9%
2017	20	19.8%
2018	17	16.8%
2019	16	15.8%
2020	5	5.0%
2021	2	2.0%
2022	3	3.0%
2023	1	1.0%

Which technologies does CuRNA, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 100

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 100

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 86

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 48

C12Y - Enzymes 17

Y10T - Technical Subjects Covered BY Former US Classification 16

Y02A - Technologies FOR Adaptation TO Climate Change 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

C07K - Peptides 7

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#3,623

of 49,997 tracked assignees

Innovation Score

37.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

CuRNA, Inc.'s patent record in context - here's where to go next.

CuRNA, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 99% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,623 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CuRNA, Inc. against Chang Chun Petrochemical Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.